Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy Meeting Abstract


Authors: Scaltriti, M.; Carmona, F. J.; Toska, E.; Cocco, E.; Hyman, D.; Cutler, R.; Avogadri-Connors, F.; Wick, M. J.; Papadopoulos, K. P.; Lalani, A. S.; Baselga, J.
Abstract Title: Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy
Meeting Title: 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 69
Issue: Suppl. 1
Meeting Dates: 2016 Nov 29-Dec 2
Meeting Location: Munich, Germany
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2016-12-01
Start Page: S125
Language: English
ACCESSION: WOS:000390503500366
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)32971-9
Notes: Meeting Abstract: 378 -- 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 29-DEC 02, 2016 -- Munich, GERMANY -- Source: Wos
Altmetric Score
MSK Authors
  1. David Hyman
    181 Hyman
  2. Jose T Baselga
    394 Baselga
  3. Eneda   Toska
    10 Toska
  4. Emiliano Cocco
    9 Cocco